Aspen Aerogels (ASPN) to Release Quarterly Earnings on Wednesday

Aspen Aerogels (NYSE:ASPN) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, November 6th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter. Aspen Aerogels has set its FY24 guidance at more than $0.09 EPS.Persons interested in registering for the company’s earnings conference call can do so using this link.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.16. The business had revenue of $117.80 million during the quarter, compared to the consensus estimate of $101.99 million. Aspen Aerogels had a return on equity of 0.74% and a net margin of 0.39%. The business’s revenue for the quarter was up 144.4% on a year-over-year basis. During the same period in the previous year, the company posted ($0.22) earnings per share. On average, analysts expect Aspen Aerogels to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Aspen Aerogels Stock Up 1.2 %

Shares of NYSE:ASPN opened at $18.05 on Monday. The company has a quick ratio of 2.82, a current ratio of 3.46 and a debt-to-equity ratio of 0.23. Aspen Aerogels has a fifty-two week low of $8.05 and a fifty-two week high of $33.15. The stock has a market cap of $1.39 billion, a price-to-earnings ratio of -1,803.20 and a beta of 2.21. The firm’s 50 day moving average price is $24.29 and its 200 day moving average price is $24.67.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on ASPN. TD Cowen lifted their price objective on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. HC Wainwright reiterated a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a report on Wednesday, October 16th. Benchmark restated a “buy” rating and set a $14.00 target price on shares of Aspen Aerogels in a research note on Thursday, August 8th. Barclays began coverage on shares of Aspen Aerogels in a research note on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 price target on the stock. Finally, Roth Mkm restated a “buy” rating and set a $36.00 price objective on shares of Aspen Aerogels in a research report on Wednesday, August 21st. One analyst has rated the stock with a sell rating, nine have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Aspen Aerogels presently has a consensus rating of “Moderate Buy” and an average price target of $29.40.

Insider Activity

In related news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now owns 483,640 shares in the company, valued at $14,523,709.20. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at $14,523,709.20. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the transaction, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 4.30% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.